Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Comment by Mil_Man54on Sep 29, 2021 7:07pm
54 Views
Post# 33941412

RE:RE:RE:RE:RE:RE:RE:RE:Ignore the haters

RE:RE:RE:RE:RE:RE:RE:RE:Ignore the hatersIs Rosenberg honestly trying to convince us that FSD swooped in to to save Lucid and that FSD is the ONLY company in the last 10 yrs to realize the potential of the molecule that Lucid developed......that should be the question asked here.......and which definitely needs to be answered.......FSD didn't get lucky and stumble onto this.......there is something in the background that has nothing to do with the science and needs to see the light of day......

DavidRosenberg wrote:
DavidRosenberg wrote:
Mil_Man54 wrote: See there's the problem......FSD HAS NO DATA....JUST HYPE......but you are treating this board as if they are competing with the big boys and the data is forthcoming.......IT IS NOT.....nothing is coming anytime soon.......

DavidRosenberg wrote:
Mil_Man54 wrote: Rosenberg constantly deflects.....and ignores the history of FSD to include the incompetence and complicense of the BoD which includes AD that equally contributed to the failures of FSD....but Rosenberg is adament to put the full blame on Raza Bokari and the only blame to be had by anyone else is that they made a mistake in hiring him.......that is complete BS mean't to absolve AD of any accountabilty........he has prsented ZERO hard data to support anything he says.....and FYI...hard data from successful companies does not represent FSD or translate to its success......I challenge you to produce one item of data to support your assertions about FSD.....and telling us how much cash they have is NOT relevant.......money in a bankl account DOES NOT translate to success.....and an aging building that's been on the market for a few years now does not count as a viable asset....it is a never ending expense and liability.....and I want my money back as much as anyone...but I refuse to lower myself to your tactics of pumping and misleading investors......

DavidRosenberg wrote:
Mil_Man54 wrote: WRONG.....focus on the whole picture.....not intentions going forward.......Rosenberg will always deflect when it comes to FSD's past failures........


DavidRosenberg wrote:

Focus on what the company is doing and wants to do

cheers


 


 

 

i won't deflect , raza made a mess of things since 2019 , AD and the board choose raza but now there is a huge reset happening 

Only hard data and results will ultimately decide 

I want FSD stock to go up who doesn't 


 


 

 


lucid psychecuticals has an important role in making fsd Pharma known around the o bestie community for psychedelic clinical trials 

it psychedelic industry starts entering a bull market and analysts recognize FSD Pharma data then we could see movement and stop fighting and bashing each other ??


https://www.bloomberg.com/news/articles/2021-09-27/drug-startup-raises-70-million-for-psychedelics-without-a-trip?utm_campaign=socialflow-organic&utm_medium=social&utm_content=business&cmpid=socialflow-facebook-business&utm_source=facebook&fbclid=IwAR1MMam6f0K9dRslDpZb6BvPwrwVJ-oEzlFSiSqlyXTMfiH8HEn8RnOFJEU


 


data from ELYM could impact FSD201 molecule since both companies have PEA maybe it's smarter to see ELYM complete their trial first before exploring other options ?
 


if you listened to the interview it said that UHN and lucid have a patent on the molecule how many years have they been researching those drug candidates ? 10 years? Why only now are they able to do or start the trials maybe because of the money FSD can infuse into the trials ?



<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse